Literature DB >> 7002668

The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion.

A Pietri, F L Dunn, P Raskin.   

Abstract

We studied short-term changes in plasma lipid levels in type I diabetics treated with either a conventional insulin regimen or continuous subcutaneous insulin infusion. Mean plasma glucose dropped from 260 +/- 18 to 134 +/- 8 mg/dl when conventional treatment was used and from 194 +/- 18 to 108 +/- 8 mg/dl with CSII. Both forms of therapy were associated with a significant fall in plasma triglyceride levels. However, only CSII treatment produced significant changes in total plasma cholesterol and LDL cholesterol levels. Total cholesterol fell from 195 +/- 17 mg/dl to 161 +/- 11 mg/dl and LDL cholesterol fell from 129 +/- 13 mg/dl to 102 +/- 9 mg/dl. We conclude that improved diabetic control by any method is effective in lowering plasma triglyceride levels, but it requires almost perfect metabolic control to affect plasma cholesterol and LDL cholesterol levels. The changes in plasma lipid and lipoprotein achieved with CSII may favorably alter the prediction for the development of premature atherosclerosis in our patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002668     DOI: 10.2337/diab.29.12.1001

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

Review 1.  Treatment of diabetes: the effect on serum lipids and lipoproteins.

Authors:  P K Merrin; R S Elkeles
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 2.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

3.  Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement.

Authors:  G F Lewis; N M O'Meara; V G Cabana; J D Blackman; W L Pugh; A F Druetzler; J R Lukens; G S Getz; K S Polonsky
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

4.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

Authors:  T Jensen; S Stender; T Deckert
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

5.  Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.

Authors:  E Manzato; A Zambon; S Zambon; R Nosadini; A Doria; R Marin; G Crepaldi
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

6.  Analysis of membrane fluidity alterations and lipid disorders in type I diabetic children and adolescents.

Authors:  C Watała; M Kordacka; A Loba; Z Jóźwiak; S Nowak
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

7.  The treatment of unstable type I diabetes: conventional versus portable pump insulin administration.

Authors:  P Cavallo-Perin; G Pagano; V Tagliaferro; P Jarre; A Ozzello; G Lenti
Journal:  Acta Diabetol Lat       Date:  1983 Oct-Dec

8.  Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.

Authors:  N al-Muhtaseb; A R al-Yuosuf; J S Bajaj
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

9.  Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.

Authors:  S L Jones; C F Close; M B Mattock; R J Jarrett; H Keen; G C Viberti
Journal:  BMJ       Date:  1989-02-25

10.  Serum lipid and lipoprotein levels and metabolic control in insulin-treated diabetics.

Authors:  D Fedele; R Fellin; A Lapolla; G Baggio; F De Romedi; F Frigato; G Crepaldi
Journal:  Acta Diabetol Lat       Date:  1982 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.